Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Transgenic autoinhibition of p21-activated kinase exacerbates synaptic impairments and fronto-dependent behavioral deficits in an animal model of Alzheimer's disease.

Bories C, Arsenault D, Lemire M, Tremblay C, De Koninck Y, Calon F.

Aging (Albany NY). 2017 May 16;9(5):1386-1403. doi: 10.18632/aging.101239.

2.

FDG-PET and Neuropsychiatric Symptoms among Cognitively Normal Elderly Persons: The Mayo Clinic Study of Aging.

Krell-Roesch J, Ruider H, Lowe VJ, Stokin GB, Pink A, Roberts RO, Mielke MM, Knopman DS, Christianson TJ, Machulda MM, Jack CR, Petersen RC, Geda YE.

J Alzheimers Dis. 2016 Jul 14;53(4):1609-16. doi: 10.3233/JAD-160326.

3.

Principles and management of neuropsychiatric symptoms in Alzheimer's dementia.

Nowrangi MA, Lyketsos CG, Rosenberg PB.

Alzheimers Res Ther. 2015 Jan 29;7(1):12. doi: 10.1186/s13195-015-0096-3. Review.

4.

Optimal treatment of Alzheimer's disease psychosis: challenges and solutions.

Koppel J, Greenwald BS.

Neuropsychiatr Dis Treat. 2014 Nov 24;10:2253-62. doi: 10.2147/NDT.S60837. eCollection 2014. Review.

5.

Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease.

Hirao K, Pontone GM, Smith GS.

Neurosci Biobehav Rev. 2015 Feb;49:157-70. doi: 10.1016/j.neubiorev.2014.11.010. Epub 2014 Nov 20. Review.

6.

Neural basis of three dimensions of agitated behaviors in patients with Alzheimer disease.

Banno K, Nakaaki S, Sato J, Torii K, Narumoto J, Miyata J, Hirono N, Furukawa TA, Mimura M, Akechi T.

Neuropsychiatr Dis Treat. 2014 Feb 17;10:339-48. doi: 10.2147/NDT.S57522. eCollection 2014.

7.

TAR DNA-binding protein 43 pathology in Alzheimer's disease with psychosis.

Vatsavayi AV, Kofler J, Demichele-Sweet MA, Murray PS, Lopez OL, Sweet RA.

Int Psychogeriatr. 2014 Jun;26(6):987-94. doi: 10.1017/S1041610214000246. Epub 2014 Mar 4.

8.

Cognitive and neuropsychiatric impairment in cerebral radionecrosis patients after radiotherapy of nasopharyngeal carcinoma.

Wu X, Gu M, Zhou G, Xu X, Wu M, Huang H.

BMC Neurol. 2014 Jan 13;14:10. doi: 10.1186/1471-2377-14-10.

9.

Hyperphosphorylated tau is elevated in Alzheimer's disease with psychosis.

Murray PS, Kirkwood CM, Gray MC, Fish KN, Ikonomovic MD, Hamilton RL, Kofler JK, Klunk WE, Lopez OL, Sweet RA.

J Alzheimers Dis. 2014;39(4):759-73. doi: 10.3233/JAD-131166.

10.

Neuropsychiatric symptoms and regional neocortical atrophy in mild cognitive impairment and Alzheimer's disease.

Rafii MS, Taylor CS, Kim HT, Desikan RS, Fleisher AS, Katibian D, Brewer JB, Dale AM, Aisen PS.

Am J Alzheimers Dis Other Demen. 2014 Mar;29(2):159-65. doi: 10.1177/1533317513507373. Epub 2013 Oct 27.

11.

Psychosis in Alzheimer's disease.

Murray PS, Kumar S, Demichele-Sweet MA, Sweet RA.

Biol Psychiatry. 2014 Apr 1;75(7):542-52. doi: 10.1016/j.biopsych.2013.08.020. Epub 2013 Oct 6. Review.

12.

Neurobiology of delusions, memory, and insight in Alzheimer disease.

Sultzer DL, Leskin LP, Melrose RJ, Harwood DG, Narvaez TA, Ando TK, Mandelkern MA.

Am J Geriatr Psychiatry. 2014 Nov;22(11):1346-55. doi: 10.1016/j.jagp.2013.06.005. Epub 2013 Sep 8.

13.

Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease.

Trzepacz PT, Yu P, Bhamidipati PK, Willis B, Forrester T, Tabas L, Schwarz AJ, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2013 Oct;9(5 Suppl):S95-S104.e1. doi: 10.1016/j.jalz.2012.10.005. Epub 2012 Dec 17.

14.

Behavioral and psychological symptoms of dementia.

Cerejeira J, Lagarto L, Mukaetova-Ladinska EB.

Front Neurol. 2012 May 7;3:73. doi: 10.3389/fneur.2012.00073. eCollection 2012.

15.

β-Amyloid 42/40 ratio and kalirin expression in Alzheimer disease with psychosis.

Murray PS, Kirkwood CM, Gray MC, Ikonomovic MD, Paljug WR, Abrahamson EE, Henteleff RA, Hamilton RL, Kofler JK, Klunk WE, Lopez OL, Penzes P, Sweet RA.

Neurobiol Aging. 2012 Dec;33(12):2807-16. doi: 10.1016/j.neurobiolaging.2012.02.015. Epub 2012 Mar 17.

16.

Comparing the Neuropsychiatric Profile of Patients with Alzheimer Disease Who Present Spared versus Impaired Executive Functioning.

Gleichgerrcht E, Chade A, Torralva T, Roca M, Manes F.

Curr Gerontol Geriatr Res. 2011;2011:514059. doi: 10.1155/2011/514059. Epub 2011 Oct 26.

17.

Neuropsychiatric symptoms in Alzheimer's disease.

Lyketsos CG, Carrillo MC, Ryan JM, Khachaturian AS, Trzepacz P, Amatniek J, Cedarbaum J, Brashear R, Miller DS.

Alzheimers Dement. 2011 Sep;7(5):532-9. doi: 10.1016/j.jalz.2011.05.2410.

18.

Cerebral correlates of psychotic syndromes in neurodegenerative diseases.

Jellinger KA.

J Cell Mol Med. 2012 May;16(5):995-1012. doi: 10.1111/j.1582-4934.2011.01311.x. Review.

19.

Executive dysfunction in Alzheimer disease.

Swanberg MM, Tractenberg RE, Mohs R, Thal LJ, Cummings JL.

Arch Neurol. 2004 Apr;61(4):556-60.

20.

The neurobehavioural rating scale-revised: sensitivity and validity in closed head injury assessment.

McCauley SR, Levin HS, Vanier M, Mazaux JM, Boake C, Goldfader PR, Rockers D, Butters M, Kareken DA, Lambert J, Clifton GL.

J Neurol Neurosurg Psychiatry. 2001 Nov;71(5):643-51.

Supplemental Content

Support Center